Welcome to Multibagg AI
Log in to access personalized features
Discovery themes featuring this stockBearish
0
Neutral
14
Bullish
0
Bearish
0
Neutral
46
Bullish
0
Bearish
0
Neutral
32
Bullish
0
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Dashboard
Portfolio
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Cian Healthcare Limited is a WHO-GMP & ISO-9001:2015 certified company that manufactures a wide range of pharmaceutical, nutraceutical, ayurvedic, cosmeceuticals, sexual wellness, and food supplement products.
It operates under various business models including brand business, export, third-party manufacturing, and government supplies.
Cian Healthcare has developed over 1,000 formulations and 2,000 brands, indicating significant innovation and breadth in product offerings.
The company has licenses and approvals for a wide range of manufacturing services, including tablets and capsules, and conducts chemical, instrumental, and microbiology analysis.
Its manufacturing capabilities extend to producing veterinary products for major clients like SAVAvet and Venky's, showcasing its diverse operational scope.
Pharmaceuticals & Biotechnology
Pharmaceuticals
21 Cr
Low Risk
-0.9
34.3
—
2.4
8.26
3.11
Sales CAGR
Profit CAGR
ROE
ROCE
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Cian Healthcare Ltd (CHCL) is currently trading at N/A per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Cian Healthcare Limited is a WHO-GMP & ISO-9001:2015 certified company that manufactures a wide range of pharmaceutical, nutraceutical, ayurvedic, cosmeceuticals, sexual wellness, and food supplement products. It operates under various business models including brand business, export, third-party manufacturing, and government supplies. Cian Healthcare has developed over 1,000 formulations and 2,000 brands, indicating significant innovation and breadth in product offerings. The company has licenses and approvals for a wide range of manufacturing services, including tablets and capsules, and conducts chemical, instrumental, and microbiology analysis. Its manufacturing capabilities extend to producing veterinary products for major clients like SAVAvet and Venky's, showcasing its diverse operational scope.
Over the past 52 weeks, Cian Healthcare Ltd has traded between a low of ₹3.11 and a high of ₹8.26. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Cian Healthcare Ltd has a market capitalization of approximately 20.65. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Cian Healthcare Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -0.89 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 20.65 Cr, Cian Healthcare Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Cian Healthcare Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Cian Healthcare Ltd is -0.89. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
74.70 | 22 Cr | 28.77 | 1.94 | 0.00 | 6.73 | 9.78 | 6.19 | ||
59.32 | 22 Cr | -5.35 | 0.00 | 0.00 | 67.65 | -85.76 | -14.80 | ||
40.00 | 22 Cr | 14.58 | 0.94 | 0.00 | 6.49 | 7.62 | 0.44 | ||
23.20 | 22 Cr | 8.82 | 1.15 | 0.00 | 13.09 | 13.74 | 4.84 | ||
8.26 | 21 Cr | -0.89 | 2.42 | 0.00 | -117.84 | -25.84 | -37.84 | ||
11.65 | 21 Cr | 24.80 | 0.66 | 0.00 | 2.67 | 6.38 | 0.70 | ||
35.00 | 20 Cr | 34.98 | 1.53 | 0.00 | 4.23 | 5.80 | 2.73 | ||
| Median: 7 Co. | — | 35.00 | 22 Cr | 14.58 | 1.15 | 0.00 | 6.49 | 6.38 | 0.70 |
Postal Ballot Notice
Cian Healthcare dispatched a postal ballot (cut-off Jun 5) with remote e‑voting from Jun 10–Jul 9, 2026 seeking approval for nine resolutions including related‑party transactions, sale of undertaking, enhanced borrowings, loans/guarantees and director appointments.
Postal Ballot Notice
Cian Healthcare dispatched a postal ballot (mailed Jun 9, 2026) for remote e‑voting (10 Jun–9 Jul 2026) on nine resolutions including material related‑party transactions, disposal powers, higher borrowing/investment limits, loans/guarantees and MD & director appointments; results by Jul 13, 2026.
